Skip to main content

Inspection visit

Health inspection

Kirkwood ManorCMS #4557322 citations on this visit
2 citations recorded

Inspector’s narrative

What the inspector wrote

This survey cited 2 deficiencies. The full statement and the facility’s plan of correction follow, verbatim from the federal record.

F 0755 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharmacist. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview, and record review, the facility failed to provide pharmaceutical services (including procedures that assure the accurate acquiring, receiving, dispensing, and administering of all drugs and biologicals) to meet the needs of each resident for 1 of 3 residents (Resident #1) reviewed for pharmacy services. LVN A administered Resident #1's insulin from a flex pen (Aspart) for diabetes at lunchtime to Resident #1, when it was not labeled with the resident's name. This failure could place residents at risk of inaccurate drug administration and not having appropriate therapeutic effects. The findings included: Record review of Resident #1's face sheet, dated 06/03/2025, revealed she was a [AGE] year-old female who was initially admitted to the facility on [DATE] and readmitted on [DATE]. Her diagnoses included: cerebral palsy (a group of neurological disorders that affect movement, balance and posture), type 2 diabetes mellitus (the most common form of diabetes characterized by the body's inability to properly use insulin, leading to high sugar levels), mild intellectual disabilities (deficits in intellectual functions pertaining to abstract/theoretical thinking), anxiety (a feeling of worry, unease, or nervousness, often accompanied by physical symptoms like a racing heart or rapid breathing and need for assistance with personal care. Record review of Resident #1's Annual MDS assessment, dated 05/04/2025, revealed the resident rarely or never understood others and could rarely or never understand. She was not a candidate for a BIMS which indicated she was severely cognitively impaired. She was dependent on staff for her ADLs, and she received insulin injections daily. Record review of Resident #1's physician's order, dated 12/27/2024, revealed the resident had the order of Fiasp (brand name) Pen Fill Subcutaneous Solution Cartridge 100 UNIT/ML (Insulin Aspart (with Niacinamide, a form of Vitamin B3) Inject as per sliding scale: if 150 - 200 = 2; 201 - 250 = 4; 251 - 300 = 6; 301 - 350 = 8; 351 - 400 = 10, subcutaneously with meals for DM If greater than 401notify MD Phone Active 03/25/2025. Record review of Resident #1's MAR, dated from 06/01/2025 to 06/30/2025, revealed Resident #1 was receiving Fiasp Pen Fill subcutaneous Solution Pen Injector 100 unit/ml (insulin Aspart) inject as per sliding scale. (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 4 Event ID: 455732 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 455732 B. Wing A. Building (X3) DATE SURVEY COMPLETED 06/04/2025 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Kirkwood Manor 2590 Loop 337 N New Braunfels, TX 78130 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few Observation on 06/03/2025 at 12:15 p.m., revealed LVN A proceeded to administer Resident #1 her insulin. The insulin pen was lying on a medication tray, had an open date of 05/20/25 and an expiration date. The insulin pen which was Aspart, 100 UNITS/ML did not have Resident #1's name. In an interview on 06/03/2025 at 12:17 p.m., with LVN A she stated she usually labels the pens with the resident's names and did not know why the insulin pen was not labeled. Observation on 06/03/2025 at 12:19 p.m., revealed LVN A writing with a marker, Resident #1's name on the Aspart insulin pen. In an interview on 06/03/2025 at 12:20 p.m., LVN A, stated she knew the Aspart insulin pen belonged to Resident #1 because she was the only resident on the 400 Hall with that type of insulin. Observation on 06/03/2025 at 12:24 p.m., LVN A, proceeded to administer Resident #1 4 units of the Aspart insulin as ordered for her blood sugar sliding scale. In an Interview on 06/03/2025 at 12:46 p.m., the DON, stated insulin pens needed to be labeled. He said he was not aware Resident #1's pen was not labeled. He stated Resident #1's family brought in her insulin and the pen should not be placed on the medication cart without her name. He stated he was accountable for the nursing care at the facility and nurses were trained on the 6 rights of medication administration. He stated it was not acceptable to administer insulin to Resident #1 without a name on the insulin pen or assume an unlabeled pen belonged to a specific resident. He stated the consequences could be cross contamination of a blood borne pathogen. He stated the unlabeled insulin pen needed to be discarded when LVN A found it on the cart. Interview on 06/04/2025 at 12:50 p.m., LVN A, stated she knew not to give residents medications that was unlabeled. She stated she was trained not to do that, and did not think about it at the time, but the consequences could be cross contamination. Interview on 06/04/2025 at 1:36 p.m., the ADON, stated when insulin pens arrived at the facility they were logged in and accounted for, however, he had not encountered an unlabeled one. He stated Resident #1's family brought the insulin in and must have missed labeling one of the pens. He stated he did not know how it was found on a cart without a label. He stated he trained LVN A and provided a skills checklist which she completed. Record review of LVN A's medication administration skills checklist dated 12/12/2024 reflected Pre-Administration, gather medication for one resident at a time while adhering to the six rights of medication administration (drug, dose, route, time, resident and documentation), select correct drug and compare name on medication label with the MAR. Record review of the facility policy and procedure titled Section: Medication Administration, Subject: Administration of Medication dated revised 07/2013 and reviewed 06/2022 reflected The seven rights of medication administration are as follows to ensure safety and accuracy of administration, 1. Right Resident, 2. Right Time, 3. Right Medication, 4. Right Dose, 5. Right Route, 6. Right Documentation and 7. Right Diagnosis. FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 455732 If continuation sheet Page 2 of 4 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 455732 B. Wing A. Building (X3) DATE SURVEY COMPLETED 06/04/2025 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Kirkwood Manor 2590 Loop 337 N New Braunfels, TX 78130 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted professional principles; and all drugs and biologicals must be stored in locked compartments, separately locked, compartments for controlled drugs. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observations, interviews, and record review, the facility failed to ensure all drugs and biologicals were labeled for 1 of 3 residents (Resident #1) reviewed for medication labeling. 2. An insulin flex pen (Aspart) for diabetes had no resident's name labeled and was found on the 400-hall medication cart on 06/03/2024 and assumed by LVN A to belong to Resident #1. This failure could place residents at risk of use of the medication for more than one resident which could result in contamination of a blood borne pathogen. The findings included: Record review of Resident #1's face sheet, dated 06/03/2025, revealed she was a [AGE] year-old female who was initially admitted to the facility on [DATE] and readmitted on [DATE]. Her diagnoses included: cerebral palsy (a group of neurological disorders that affect movement, balance and posture), type 2 diabetes mellitus (the most common form of diabetes characterized by the body's inability to properly use insulin, leading to high sugar levels), mild intellectual disabilities (deficits in intellectual functions pertaining to abstract/theoretical thinking), anxiety (a feeling of worry, unease, or nervousness, often accompanied by physical symptoms like a racing heart or rapid breathing and need for assistance with personal care. Record review of Resident #1's Annual MDS assessment, dated 05/04/2025, revealed the resident rarely or never understood others and could rarely or never understand. She was not a candidate for a BIMS which indicated she was severely cognitively impaired. She was dependent on staff for her ADLs, and she received insulin injections daily. Record review of Resident #1's physician's order, dated 12/27/2024, revealed the resident had the order of Fiasp (brand name) Pen Fill Subcutaneous Solution Cartridge 100 UNIT/ML (Insulin Aspart (with Niacinamide, a form of Vitamin B3) Inject as per sliding scale: if 150 - 200 = 2; 201 - 250 = 4; 251 - 300 = 6; 301 - 350 = 8; 351 - 400 = 10, subcutaneously with meals for DM If greater than 401notify MD Phone Active 03/25/2025. Record review of Resident #1's MAR, dated from 06/01/2025 to 06/30/2025, revealed Resident #1 was receiving Fiasp Pen Fill subcutaneous Solution Pen Injector 100 unit/ml (insulin Aspart) inject as per sliding scale. Observation on 06/03/2025 at 12:15 p.m. revealed LVN A proceeded to administer Resident #1 her PRN insulin. The insulin pen was lying on a medication tray, had an open date of 05/20/25 and an expiration date. The insulin pen which was Aspart, 100 UNITS/ML did not have Resident #1's name. In an interview on 06/03/2025 at 12:17 p.m., LVN A, stated she usually labels the pens with the resident's names and did not know why the insulin pen was not labeled. Observation on 06/03/2025 at 12:19 p.m. revealed LVN A writing with a marker, Resident #1's name on the Aspart insulin pen. (continued on next page) FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 455732 If continuation sheet Page 3 of 4 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 455732 B. Wing A. Building (X3) DATE SURVEY COMPLETED 06/04/2025 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Kirkwood Manor 2590 Loop 337 N New Braunfels, TX 78130 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761 Level of Harm - Minimal harm or potential for actual harm In an interview on 06/03/2025 at 12:20 p.m., LVN A, stated she knew the Aspart insulin pen belonged to Resident #1 because she was the only resident on the 400 Hall with that type of insulin. Observation on 06/03/2025 at 12:24 p.m. of LVN A, she proceeded to administer Resident #1 4 units of the Aspart insulin as ordered for her blood sugar sliding scale. Residents Affected - Few In an Interview on 06/03/2025 at 12:46 p.m., the DON, stated insulin pens needed to be labeled. He said he was not aware Resident #1's pens were not labeled. He stated Resident #1's family brought in her insulin and the pen should not be placed on the medication cart without her name. He stated the consequences could be cross contamination of a blood borne pathogen. He stated the unlabeled insulin pen needed to be discarded when LVN A found it on the cart. Interview on 06/04/2025 at 12:50 p.m., LVN A, stated Resident #1's insulin pens was provided by the family and the family member would label them. She did not know how the pen was on the medication cart without a resident label. Interview on 06/04/2025 at 1:36 p.m. with the ADON, he stated when insulin pens arrived at the facility they were logged in and accounted for, however, he had not encountered an unlabeled one. He stated Resident #1's family brought the insulin in and must have missed labeling one of the pens. He stated he did not know how it was found on a cart without a label. He stated it would be difficult to identify whose medication it was without a label and would not be safe. Interview on 06/04/2025 at 2:08 p.m. with RN B, she stated an unlabeled insulin pen in the medication cart needed to be discarded. Record review of the facility policy and procedure titled Section: Medication Administration, Subject: Administration of Medication dated revised 07/2013 and reviewed 06/2022 reflected The seven rights of medication administration are as follows to ensure safety and accuracy of administration, 1. Right Resident, 2. Right Time, 3. Right Medication, 4. Right Dose, 5. Right Route, 6. Right Documentation and 7. Right Diagnosis. Record review of the facility policy and procedure titled Section: Care and Treatment, Subject: Medication Access and Storage revised 05/2025 reflected: Medications labeled for individual residents are stored separately from floor stock medications. FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 455732 If continuation sheet Page 4 of 4

Reading this as a family member? Your long-term care ombudsman is a free advocate for residents and families.

Back to top

Citations

2 citations recorded*CMS

What do CMS severity letters mean?

Serious (G-L). Actual harm to a resident, or immediate jeopardy. Codes G through I indicate actual harm; J through L indicate immediate jeopardy to resident health or safety.

General (A-F). No actual harm found, or harm that is minimal. The facility must still submit a Plan of Correction. Most CMS citations land here.

Each letter combines severity with scope: how many residents the deficiency affected.

  • 0755GeneralS&S Dpotential for harm

    F755 - Pharmacy Services

    Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharmacist.

  • 0761GeneralS&S Dpotential for harm

    F761 - Labeling of Drugs and Biologicals

    Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted professional principles; and all drugs and biologicals must be stored in locked compartments, separately locked, compartments for controlled drugs.

FAQ · About this visit

Common questions about this visit

What happened during the June 4, 2025 survey of Kirkwood Manor?

This was a inspection survey of Kirkwood Manor on June 4, 2025. The surveyor cited 2 deficiencies, recorded on the federal Form 2567 statement of deficiencies.

Were any deficiencies cited at Kirkwood Manor on June 4, 2025?

Yes, 2 deficiencies were cited, each with a CMS Scope and Severity grade. The first was: "Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharm..."

What type of survey was this?

This was a inspection survey conducted by state surveyors under federal Centers for Medicare & Medicaid Services (CMS) oversight. Findings are published on CMS Care Compare.

Share this reportEmail

Next steps

Concerned about a resident’s care?Find your local ombudsman through the Eldercare Locatoror file a complaint with your state survey agency.

Researching this visit professionally?Book a 15-minute calland we will walk through what we have on file.

Data from CMS Care Compare public records. Dataset last refreshed . If you believe any information is inaccurate, report it here.